The shortcomings in the care and treatment of Alzheimer’s have become even more glaring in the Covid-19 era.
The Other Pandemic: What to Do About the Coming Alzheimer’s Crisis
Covid-19 is exposing costly gaps in the treatment of Alzheimer's disease. That threatens livelihoods—and the broader economy. Is a breakthrough drug on the horizon?